173 related articles for article (PubMed ID: 30580013)
1. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
2. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
[TBL] [Abstract][Full Text] [Related]
4. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004.
Advani A; Donnelly D; Gustafsson L; Hallander HO
APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296
[TBL] [Abstract][Full Text] [Related]
5. Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.
Mosiej E; Augustynowicz E; Zawadka M; Dabrowski W; Lutyńska A
J Clin Microbiol; 2011 Apr; 49(4):1452-7. PubMed ID: 21307213
[TBL] [Abstract][Full Text] [Related]
6. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
Niinikoski V; Barkoff AM; Mertsola J; He Q
Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
[TBL] [Abstract][Full Text] [Related]
7. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
[TBL] [Abstract][Full Text] [Related]
8. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
Kodama A; Kamachi K; Horiuchi Y; Konda T; Arakawa Y
J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
[TBL] [Abstract][Full Text] [Related]
9. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.
Litt DJ; Neal SE; Fry NK
J Clin Microbiol; 2009 Mar; 47(3):680-8. PubMed ID: 19158267
[TBL] [Abstract][Full Text] [Related]
10. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
[TBL] [Abstract][Full Text] [Related]
11. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
Kallonen T; Gröndahl-Yli-Hannuksela K; Elomaa A; Lutyńska A; Fry NK; Mertsola J; He Q
Infect Genet Evol; 2011 Dec; 11(8):2034-42. PubMed ID: 21964035
[TBL] [Abstract][Full Text] [Related]
12. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
13. Small mutations in Bordetella pertussis are associated with selective sweeps.
van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR
PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
[TBL] [Abstract][Full Text] [Related]
16. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomics of whole-cell pertussis vaccine strains from India.
Alai S; Ghattargi VC; Gautam M; Patel K; Pawar SP; Dhotre DP; Shaligram U; Gairola S
BMC Genomics; 2020 May; 21(1):345. PubMed ID: 32381023
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.
Prygiel M; Mosiej E; Wdowiak K; Górska P; Polak M; Lis K; Krysztopa-Grzybowska K; Zasada AA
Med Microbiol Immunol; 2021 Dec; 210(5-6):251-262. PubMed ID: 34338880
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
Byrne S; Slack AT
BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
[TBL] [Abstract][Full Text] [Related]
20. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
Bouchez V; Brun D; Cantinelli T; Dore G; Njamkepo E; Guiso N
Vaccine; 2009 Oct; 27(43):6034-41. PubMed ID: 19666155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
